The ANNE® One platform is a wireless, flexible, and rechargeable monitoring system indicated for the measurement of multiple vital signs in the healthcare setting for clinical decision-making by medical providers for patients 18 years or older. It includes a companion mobile device pre-loaded with ANNE® View software to visualize clinical data in real time.

Health monitoring is very important in terms of prevention, particularly if the early detection of diseases can reduce suffering and medical costs. The diagnosis and prompt treatment of various diseases can radically improve alternatives for the medical treatment of the patient.

ANNE® One system has been deployed extensively in thousands of patients across a wide range of geographic locations including low-resource settings with scientific publications in Nature Medicine, Lancet Digital Medicine, and Proceedings of the National Academy of Medicine. With U.S. government support, Sibel Health has also deployed the ANNE®One platform to assess patients with COVID-19. Jong Yoon Lee, co-founder and VP of Software Engineering, notes "the ability for our system to monitor a wide range of vital signs using a dual-sensor platform is very powerful and unique. The interoperability and the extendability of the system will allow us to use this approval as a foundation to expand to other novel indications and make monitoring accessible to everyone."